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Evaluating functional capacity, and mortality effects 
in the presence of atrial electromechanical conduction delay 
in patients with systolic heart failure
Objective: Atrial functions are relatively suppressed in heart failure (HF). We aimed to investigate the associations of intra- and inter-atrial 
electromechanical conduction delay (EMCD) with functional class and mortality over a 12-month follow-up period.
Methods: The prospective study included 65 patients with systolic HF and 65 healthy subjects with normal sinus rhythm. Left ventricular (LV) 
systolic functions and left atrial (LA) dimensions and volumes were evaluated by transthoracic echocardiography. Tissue Doppler imaging (TDI) 
signals at the lateral border of the mitral annulus (lateral PA'), septal mitral annulus (septal PA'), and tricuspid annulus (tricuspid PA') were mea-
sured. Intra- and inter-atrial EMCD were calculated.
Results: Mitral inflow velocities were studied using pulsed-wave Doppler after placing the sample volume at the leaflets’ tips. The peak early (E 
wave) and late (A wave) velocities were measured. The septal annular E/E' ratio was relatively higher and lateral, septal, and right ventricular S, E', 
and A' waves were significantly lower in the HF group than in the control group (12.49±6.03 – 7.16±1.75, pE/E' <0.0001). Intra-atrial EMCD was de-
tected as 117.5 ms and inter-atrial EMCD as 127.5 ms in patients with prolonged atrial EMCD. A significant increase was found in prolonged intra- 
and inter-atrial EMCD according to functional capacity increase (p=0.012 and p=0.031, respectively). The incidence of mortality was significantly 
higher in patients with prolonged atrial EMCD (p=0.025), and 5 patients in the HF group died during the study over the 12-month follow-up period.
Conclusions: In this study, we found a relationship between prolonged atrial conduction time and increased functional class and mortality in 
patients with systolic HF. (Anatol J Cardiol 2016; 16: 579-86)
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Introduction
The atrium is not only a simple and passive heart space that 
transports blood to the ventricle but also a dynamic structure. 
The atria contribute up to 30% of the cardiac output (1); however, 
atrial function is relatively suppressed in heart failure (HF). Cur-
rently, measurement of the left atrial (LA) size is the most com-
monly used method to estimate the amount of atrial remodeling 
(2). LA volume and mechanical function have recently been iden-
tified as potential indicators of cardiac disease and arrhythmias 
(3); whereas, for all other aspects, additional parameters are 
required in the evaluation of atrial remodeling. Intra- and inter-
atrial conduction delays and non-homogeneous propagation of 
sinus impulses are well-known electrophysiological character-
istics of the atria prone to fibrillation (4).
Contrary to LA size, atrial conduction times reflect the 
amount of both electrical and structural remodeling of the atria.
Among the non-invasive and invasive methods employed for 
evaluation of inter-atrial conduction, the basic and most frequent-
ly used method is evaluation of electrocardiographic P wave du-
ration and morphology (5). The time interval between the electro-
cardiographic P wave and atrial contraction detected by M-mode 
or Doppler echocardiography is defined as atrial electromechani-
cal conduction delay (EMCD). Atrial mechanical activity can be 
detected from different atrial regions by Tissue Doppler imaging 
(TDI) and echocardiography with high temporal resolution (6).
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Published studies indicate that EMCD, as detected by TDI, 
increases in different patient groups, such as those with mitral 
stenosis, paroxysmal atrial fibrillation, and coronary slow-flow 
pattern (7, 8). There is no clear data about the relationship be-
tween the phasic functions of LA and EMCD in systolic HF. 
In this study, we aimed to evaluate the relationship of sup-
pressed atrial functions and functional capacity with electro-
cardiographic findings and echocardiographic parameters of 
patients with systolic HF. This study also aimed to investigate 
the correlation between intra- and inter-atrial conduction times 
measured by TDI. In addition, we investigated morbidity (func-
tional capacity, arrhythmias, cerebrovascular event, or rehospi-
talization) and mortality in patients with HF.
Methods 
Study population
Between September 2008 and November 2010, the study 
prospectively enrolled 79 consecutive patients having symptom-
atic HF with left ventricular ejection fraction (LVEF) measured 
as <50% with 2D echocardiography. Patients with newly diag-
nosed systolic HF or those with a known history of systolic HF 
were included. All patients were in sinus rhythm (SR). However, 
14 patients were excluded from the study because of valvular 
stenosis (n=4), moderate to severe valvular regurgitation (n=6), 
and detection of atrial fibrillation episodes on 24-h Holter ECG 
monitoring (n=4). The final study population consisted of 65 pa-
tients (44 men and 21 women) with HF who were in normal SR at 
the time of enrollment. In addition, 65 volunteers (37 men and 28 
women) with similar age and sex distributions and normal physi-
cal examination findings served as a control group. In the control 
group, patients over 40 years of age were included only when 
normal coronary arteries or no critical coronary artery lesions 
(<40% stenosis) were found on coronary angiography. The study 
was designed prospectively. Ethical approval was obtained from 
the Local Ethics Committee, and informed consent was obtained 
from all subjects. Other exclusion criteria were moderate or se-
vere valvular heart disease, history of asthma or use of bron-
chodilators, hypo- or hyperthyroidism, hepatic or renal failure 
(serum creatinine: >2.0 mg/dL), rhythm disturbances including 
second- or third-degree heart block, sick sinus syndrome, atrial 
fibrillation, and complete bundle brunch block. Detailed family 
and medical history were collected for all patients those con-
formed to the inclusion criteria. New York Heart Association 
(NYHA) functional capacity and medical therapies were record-
ed. ECGs were also taken. Physical examination, 12-lead ECG, 
chest X-ray, and laboratory investigations including complete 
blood count, blood biochemistry, and thyroid function tests were 
routinely performed for all patients. Twenty-four-hour ambula-
tory ECG monitoring was performed as an annual routine risk as-
sessment. Transthoracic echocardiography (TTE) was performed 
for all subjects, and they visited the hospital regularly for monthly 
check-up after enrollment during the 12-month follow-up period.
Electrocardiography
At the beginning of the study, all subjects underwent stan-
dard 12-lead ECG, acquired using Nihon-Kohden Cardiofax Q 
3190K (California, USA) electrocardiograph at a paper speed of 
25 mm/s and 10 mm/mV. All recordings were performed in the 
same quiet room through spontaneous breathing with subse-
quent 20 min of adjustment in the supine position. P wave du-
ration measurements were performed manually by 2 observers 
using calipers and magnifying lenses to precisely define the ECG 
deflection, as described in a previous study (9). The beginning of 
the P wave was defined as the point where the initial deflection 
of the P wave crossed the isoelectric line, and the end of the P 
wave was defined as the point where the final deflection of the 
P wave crossed the isoelectric line. To measure P wave disper-
sion, 12-lead surface ECGs were obtained for each subject in the 
supine position at a paper speed of 50 mm/s. The longest atrial 
conduction time measured on any of the 12 leads was defined as 
P maximum (Pmax) and the shortest time was defined as P mini-
mum (Pmin). The difference between Pmax and Pmin was cal-
culated and defined as P wave dispersion (PWD=Pmax – Pmin). 
ECG recordings with a measurable P wave in less than 10 leads 
were excluded from the analysis.
Echocardiographic examination
All echocardiographic examinations were performed with a 
Hewlett Packard Sonos 7500 cardiac ultrasound (Philips Medical 
Systems, Andover, MA, USA) scanner and 2.5–3.5-MHz trans-
ducers. All patients were examined by precordial 2-dimensional, 
Doppler and TDI according to the criteria of the American Society 
of Echocardiography (10). TTE recordings were performed while 
the patients were in the left lateral decubitus position. Apical 
4-chamber, 2-chamber, and parasternal long-axis images were 
recorded at expiratory apnea for 3 consecutive cardiac cycles. 
One-lead ECG was recorded continuously. All echocardiographic 
assessments were recorded on a VHS video tape; and the records 
were reanalyzed by 2 physicians who were blind to the study.
Left ventricular (LV) end-systolic and end-diastolic diameters 
were measured by apical 2- and 4-chamber views. LVEF and left 
atrial ejection fraction (LAEF) were evaluated by the biplane 
Simpson’s method. All valves were evaluated during echocar-
diographic examination by continuous wave Doppler color flow 
and Doppler imaging for insufficiency and stenosis. Pulmonary 
artery systolic pressure was measured by Bernoulli’s equation 
(p=4v2) from the tricuspid regurgitation jet flow. The estimated 
pulmonary artery systolic pressure was then calculated by add-
ing 5–20 mm Hg, according to the width of the inferior vena cava, 
to pulmonary artery systolic pressure (11).
LV diastolic function was evaluated by mitral inflow veloci-
ties, namely the E peak, A peak, and E/A ratio, and also by the 
deceleration time of the E wave and isovolumic relaxation time. 
In the apical 4-chamber view, the pulsed Doppler sample volume 
was placed at the level of the right ventricular tricuspid annu-
lus, LV lateral mitral annulus, and septal mitral annulus. At least 
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3 consecutive traces of all annulus were recorded. The tissue 
Doppler pattern was characterized by a positive (i.e., above the 
baseline) myocardial systolic wave (S), two negative (i.e., below 
the baseline) early diastolic waves (E'), and an atrial wave (A'). 
Every effort was made to align the pulsed-wave cursor so that 
the Doppler angle of incidence could be as close to zero as pos-
sible in the direction of these walls (12).
Inter-atrial conduction time
The time interval from the onset of P wave on the surface 
ECG to the peak of transmitral A wave (PA), which is defined as 
the inter-atrial conduction time, was measured in all groups from 
the apical 4 chambers (Fig. 1) (13).
Atrial EMCD time
The time interval from the onset of P wave on the surface 
ECG to the beginning of the late diastolic wave (A') was termed 
as atrial electromechanical coupling (PA'). It was obtained from 
the right ventricular tricuspid annulus, septal mitral annulus, and 
lateral mitral annulus and described as tricuspid PA', septal PA', 
and lateral PA', respectively. The difference between tricuspid 
PA' and septal PA' was defined as intra-atrial (ΔintraA) EMCD, 
and the difference between tricuspid PA' and lateral PA' was de-
fined as inter-atrial (ΔinterA) EMCD (Fig. 2). All measurements 
were repeated 4 times, and the average values were obtained 
for each of the atrial conduction delay times. All measurements 
were performed by 3 experienced researchers who were un-
aware about the clinical status of the subjects. If a difference of 
>5% in any of the variables measured by both the investigators 
was found, the patient was not included, whereas if the differ-
ence was <5%, the measurements were averaged (14, 15).
Twenty-four-hour ambulatory 
electrocardiographic monitoring
Twenty-four-hour ambulatory electrocardiographic moni-
toring was performed for all patients with systolic HF over the 
12-month study period for annual risk assessment, and presence 
of arrhythmias was investigated.
Statistical analysis
Statistical analyses were performed using SPSS for Win-
dows, version 18.0 (SPSS, Chicago, IL). All continuous variables 
were expressed as mean±SD, and categorical variables were 
defined in percentages. Categorical data were compared using 
the χ2 test. Continuous variables were compared between the 
groups using Student’s t-test or Mann–Whitney U test depend-
ing on whether they distributed normally or not, as tested by the 
Shapiro–Wilk test. Pearson’s correlation analysis was used to 
estimate the relationship between the test parameters. ROC 
curve analysis was performed for numerical variables to distin-
guish the patient and the control groups, and threshold values 
were also determined. A p value of <0.05 was considered to be 
statistically significant.
Results
Patient demographics
In this study, 65 patients with systolic HF and 65 healthy 
subjects as control were compared. There were no statistically 
significant differences in the etiology of patients with HF [35 pa-
tients with ischemic HF (54%) and 30 patients with non-ischemic 
HF (46%)]. There was no significant difference between both the 
groups in terms of age, sex, weight, and diastolic blood pressure. 
Lower functional capacity was found in patients with systolic HF. 
With respect to the frequency of comorbidities, type 2 diabetes 
mellitus (DM) and coronary artery disease (CAD) were signifi-
cantly more common in the HF group, whereas the frequencies 
of hypertension (HT) and hyperlipidemia (HLP) were similar be-
tween the groups. The groups were also compared in terms of 
medical treatment; it was found that use of statins and angio-
tensin-converting enzyme inhibitor/angiotensin receptor block-
er (ACE-I/ARB) was significantly higher in the HF group. There 
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Figure 1. Measurement of inter-atrial conduction time
Figure 2. Measurement of intra- and inter-atrial conduction time with the 
help of electrocardiographic rhythm tracing and pulsed-wave Doppler
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was no significant difference between the groups in terms of 
β-blocker treatment (Table 1). Among the patients, 35 (53%) were 
taking only loop diuretics, 8 (12%) were taking only aldosterone 
antagonists, and 22 (33%) were taking both in the HF group. None 
of the patients were taking antiarrhythmic drugs such as digoxin, 
propafenone, sotalol, and amiodarone.
The functional class of all patients was evaluated and we 
found that 35% (23 patients) were in class I, 43% (28 patients) 
were in class II, and 22% (14 patients) were in class III and class 
IV. There was no significant difference between the groups in 
terms of the resting heart rate (74±14.82 vs. 77.69±9.53; p<0.67). 
Five patients in the HF group died during the 12-month follow-
up period.
When echocardiography data were compared between the 
HF and control groups, LVEF was significantly lower in the HF 
group (33.1%±8.2% vs. 64.2%±5.4%, p<0.001). LAEF was also sig-
nificantly lower in the HF group (39.1%±7% vs. 61%±2%, p<0.001). 
LA volume and maximal diameter were higher in the HF group 
than in the control group (63.92±26.06 vs. 45.3±1.01, p<0.0001 
and 4.36±0.65 vs. 3.37±0.35, p<0.0001, respectively). Lateral, sep-
tal, and right ventricular S, E', and A' waves were significantly 
lower in the HF group than in the control group. The proportion 
of E velocity, which was obtained from mitral valve pulsed-wave 
Doppler flow and E' velocity, obtained from the TDI of septal an-
nular tissue (E/E') as an indicator of LV end-diastolic pressure, 
was compared and the septal annular E/E' ratio was found to 
be significantly higher in the HF group than in the control group 
(12.49±6.03 vs. 7.16±1.75, p<0.0001) (Table 2).
Comparison of inter-atrial conduction time and atrial EMCD
Inter-atrial conduction time and atrial EMCD time were signif-
icantly prolonged in the HF group in contrast to the control group. 
The Pmax (p<0.001), Pmin (p<0.001), and PWD (p<0.001) values 
were significantly higher in the HF group than in the control group 
(Table 3). At the end of the study, ROC curve analysis was per-
formed for all EMCD times used in the measurement of intra- and 
inter-atrial EMCD, and the cut-off value was determined for each 
of them (Fig. 3, 4). The threshold values of PA, tricuspid PA', septal 
PA', and lateral PA' were 102.5 ms, 107.5 ms, 127.5 ms, and 137.5 
ms, respectively. In a similar manner, the threshold values of Δin-
traA and ΔinterA was 17.5 ms and 27.5 ms, respectively (Table 4). 
Ischemic cerebrovascular events were seen in 4 patients (6%) 
(16). Thirteen patients (20%) were admitted to the hospital again 
due to HF at the end of the 12-month period. Ten patients (15.9%) 
reported arrhythmia, including atrial fibrillation (4 patients), ven-
tricular tachycardia (6 patients), and total AV block (1 patient), 
during the 12-month follow-up period (17). Correlation analy-
sis of PWD with intra- and inter-atrial dyssynchrony and other 
parameters revealed that PWD was positively correlated with 
Pmax (r=0.917, p=0.001), Pmin (r=0.431, p=0.001), intra-atrial dys-
synchrony (r=0.606, p=0.001), inter-atrial dyssynchrony (r=0.63, 
p=0.001), and PA time (r=0.454, p=0.001), whereas it was nega-
tively correlated with LVEF (r=–0.277, p=0.028) (Table 5).
Determinants of functional class
The HF group was further divided into 2 groups according 
to the functional class. Group 1 (51 patients) included func-
Table 1. General characteristics of the systolic HF and control groups
  HF group Control group P 
  (n=65) (n=65)
Age, years 55.03±14.3 50.29±12.4 0.12
Sex, male/female 44 / 21 37 / 28 0.087
Body surface area, m2 1.81±0.16 1.85±0.18 0.06
SBP, mm Hg 115.5±14.8 126.8±16.6 <0.001
DBP, mm Hg 69.5±8.9 71.4±11.7 0.31
NYHA functional class 1.71±0.8 1.01±0.12 <0.001
Disease
Hypertension 30 (47.6%) 34 (52.3%) 0.59
Hyperlipidemia 26 (41.3%) 22 (33.8%) 0.38
Diabetes mellitus 22 (34.9%) 11 (16.9%) 0.02
Coronary artery disease 34 (53.9%) 5 (7.6%) <0.001
Drug
Beta blocker 49 (75.3%) 43 (66.1%) <0.34
ACE-I/ARB 55 (87.3%) 21 (32.3%) <0.001
Statin 47 (74.6%) 20 (30.8%) <0.001
Diuretic 65 (100%) 0 (0%) 
Continuous data are expressed as mean±SD.
DBP - diastolic blood pressure; HF - heart failure; NYHA - New York Heart Association; 
SBP - systolic blood pressure
Table 2. TTE findings of the systolic HF and control groups
  HF group Control group P
LVEF 33.12±7.8 64.27±5.4 0.001
E/E' septal annulus 12.49±6.03 7.16±1.75 0.0001
LA EF 39.19±7.30 61.07±2.39 0.0001
LVDD, cm 5.63±0.98 4.30±0.26 0.0001
LVSD, cm 4.53±1.01 3.28±0.27 0.0001
LA maximal diameter, cm 4.36±0.65 3.37±0.35 0.0001
LA volume, mm3 63.92±26.06 45.3±1.01 0.0001
RV (S), cm/s 10.10±3.10 13.28±1.14 0.0001
RV (E’), cm/s 8.94±4.47 9.79±2.69 0.0001
RV (A’), cm/s 11.69±4.93 14.57±3.24 0.001
Septal (S), cm/s 5.55±1.89 7.54±1.32 0.0001
Septal (E’), cm/s 5.86±2.63 10.57±3.62 0.0001
Septal (A’), cm/s 6.72±2.85 9.48±1.80 0.0001
Lateral (S), cm/s 5.39±1.87 8.14±2.09 0.0001
Lateral (E’), cm/s 7.11±3.67 12.33±4.30 0.0001
Lateral (A’), cm/s 6.75±3.33 9.45±2.61 0.0001
Continuous data are expressed as mean±SD.
HF - heart failure; LA - left atrium; LAEF - left atrium ejection fraction; LVDD - left 
ventricular diastolic diameter; LVSD - left ventricular systolic diameter, RV - right 
ventricule
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tional classes I and II. Group 2 (12 patients) included functional 
classes III and IV. Group 1 contained a significantly lower num-
ber of patients who had prolonged intra- and inter-atrial EMCD 
(p=0.004 and p=0.012, respectively). The functional class of 
patients with prolonged intra- and inter-atrial EMCD was in-
creased during the 12-month follow-up period (p=0.012 and 
p=0.031, respectively).
Relationship between inter-atrial EMCD and morbidity
Patients with atrial EMCD had a high morbidity rate during 
the 12-month follow-up period, but it was not statistically signifi-
cant (pΔintraA=0.211, pΔinterA=0.280).
Relationship between inter-atrial EMCD and mortality
Patients with atrial EMCD had a high mortality rate during 
the 12-month follow-up period, and it was statistically signifi-
cant (pΔintraA=0.025, pΔinterA=0.017).
Discussion
In the present study, we demonstrated that TDI echocardiog-
raphy, intra- and inter-atrial EMCD are significantly related in the 
presence or absence of systolic HF. Furthermore, LA mechanical 
functions were impaired in patients with HF. TDI echocardiogra-
phy was used as a non-invasive technique to evaluate atrial con-
duction times because of its high temporal and spatial resolu-
tion (18). Using this method, we observed a significant increase 
in LA, intra-atrial and inter-atrial dyssynchrony in patients with 
systolic HF compared with patients without HF. Dyssynchrony 
was related to LAEF and LVEF. We found that ΔintraA and ΔinterA 
detected by tissue Doppler echocardiography were higher in pa-
tients with systolic HF than in healthy control subjects. In addi-
tion, lateral PA', mitral septal PA', and tricuspid PA' were higher in 
the HF group. The inter-atrial conduction time was also higher in 
the HF group, but there was no statistically significant difference 
between the 2 groups. Sanders et al. (19) found a prolonged total 
Table 3. Comparison of inter-atrial conduction time and atrial EMCD
Time, msn HF group Control group P
PA time  125.56±16.2 117.63±20.5 0.017
Lateral PA'  148.81±9.2  120.62±12.1 <0.001
Septal PA' 138.73±8.9 108.85±11.68 <0.001
Tricuspid PA' 117.14±7.7 98.54±12.4 <0.001
ΔintraA 21.51±3.8 10.46±6.23 <0.001
ΔinterA 31.67±4.3 22.08±9.3 <0.001
 Heart rate  77.69±9.53 75.34±14.82 0.67
 Pmax, msn 109.20±5.84 95.94±4.77 <0.001
 Pmin, msn 64.78±2.11 62.38±1.43 <0.001
 PWD, msn 43.79±4.94 33.5±3.02 <0.001
 PR, msn 164.89±26.71 161.88±19.84 0.42
Continuous data are expressed as mean±SD.
EMCD - electromechanical conduction delay; HF - heart failure; PWD - P wave 
dispersion; ΔinterA - interatrial electro-mechanical delay; ΔintraA - intraatrial electro 
mechanical delay
Table 4. Threshold value of inter-atrial conduction time and atrial EMCD
Time, msn Threshold value
PA time  102.5
Lateral PA'  107.5 
Septal PA' 127.5
Triküspid PA' 137.5
ΔintraA 17.5
ΔinterA 27.5
ΔinterA - interatrial electromechanical delay; ΔintraA - intraatrial electromechanical 
delay; EMCD - electomechanical conduction delay
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Figure 3. ROC curve analysis of tricuspid PA', septal PA', and lateral PA'
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right atrium (RA) activation time in patients with HF compared 
with the control group. Furthermore, Van Beeumen et al. (8) have 
shown slowing of conduction in patients with HF independent of 
the atrial tissue mass or surface area. These observations ap-
pear to be related to the structural remodeling of the atria, char-
acterized by the occurrence of fragmented atrial activity, regions 
of low voltage, atrial conduction slowing, and interstitial atrial 
fibrosis. Matrix metalloproteinase and angiotensin II levels ap-
pear to be key factors in atrial remodeling and systolic HF. More-
over, changes in atrial histopathology appear to be dependent on 
the severity of hemodynamic overload of the atria (20, 21).
Atrial EMCD has been evaluated with TDI by measuring the 
temporal relation between atrial myocardial regional motions and 
electrocardiographic P waves in some cardiac disorders such as 
paroxysmal atrial fibrillation (PAF) and congestive HF. Omi et al. (22) 
showed that patients with PAF had longer tricuspid lateral annu-
lar atrial EMCD and bigger right atrial dimensions than the control 
group. However, Pala et al. (23) found that while mitral septal annu-
lar EMCD and mitral lateral annular EMCD were significantly pro-
longed in the non-ischemic dilated cardiomyopathy group rather 
than in the control group, there was no significant prolongation 
of tricuspid lateral annular EMCD (24). Furthermore, Özer et al. (7) 
found that atrial EMCD in patients with mitral stenosis also revealed 
a significant positive correlation between prolonged mitral lateral 
annular EMCD and an increase in the LA size. Similarly, Çağlar et 
al. (25) observed a positive correlation between the right atrial area 
and tricuspid lateral annular EMCD and LA EMCD in patients with 
chronic obstructive pulmonary disease. This indicates atrial size as 
an important factor for determining atrial EMCD. In a recently pub-
lished study, De Vos et al. (14) followed 249 people with SR for nearly 
2 years; 15 of them (6%) developed AF and showed prolonged atrial 
EMCD as compared with those who did not develop AF.
In purpose of these findings, prolonged atrial EMCD by TDI 
is considered as a predictor for the development of AF. Öztürk et 
al. (26) found prolonged intra- and inter-atrial EMCD in patients 
with overt hypothyroidism in their study. As a consequence, pro-
longed intra- and inter-atrial EMCD may be associated with an 
increased risk of arrhythmias in patients with overt hypothyroid-
ism. However, in our study, we excluded all patients with hyper- 
or hypothyroidism.
In this study, we found that patients with systolic HF had a 
higher heart rate, NHYA class, coronary artery disease, and his-
tory of using β-blockers, ACE-I/ARB, diuretics, and statins. LAEF 
was also significantly lower in the patient group. LA volume and 
LV diastolic and systolic diameters were greater in the HF group 
than in the control group. In addition, lateral, septal, and tricuspid 
S, E', and A' waves were significantly lower, whereas the septal 
annular E/E' ratio was significantly higher in the HF group. This 
indicates that there was a correlation between the enlargement 
of the left atrium or left ventricle and intra- and inter-atrial EMCD. 
Moreover, we found that P wave duration and dispersions were 
significantly higher in the HF group than in the control group. In 
contrast, systolic blood pressure was lower in the systolic HF 
group despite high endothelin and angiotensin II levels in pa-
tients with HF.
In our study, patients with systolic HF had prolonged inter-
atrial conduction time (PA) measurements compared with pa-
tients in the control group. Lateral PA', septal PA', tricuspid PA', 
ΔinterA, and ΔintraA EMCD was significantly higher in the HF 
group. In addition, according to our study, intra- and inter-atrial 
electromechanical conduction times were prolonged in the HF 
group compared with the control group. Patients with prolonged 
atrial conduction time in the HF group had worse functional 
class. Functional class increased during the 12-month follow-
up period. In addition, patients with prolonged atrial conduction 
time in the HF group had higher morbidity during the 12-month 
follow-up period. However, neither an increase in morbidity nor 
an increase in the functional class was statistically significant. 
In this study, mortality was found to be higher in the systolic HF 
group with prolonged atrial conduction time during the 12-month 
follow-up period.
Study limitations
The most important limitation of our study was the small 
number of patients and a short follow-up period. A computer-as-
sisted accounting system was not used in the calculation of the 
atrial conduction time and the observer variability was not evalu-
ated. Using diuretics may affect LA volume and atrial function. 
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Figure 4. ROC curve analysis of intra- and inter-atrial EMCD time
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Conclusions
The atrial conduction time delay was seen more frequently in 
patients with systolic HF than in healthy subjects. This indicates an 
increased atrial arrhythmia risk in patients with systolic HF. In this 
study, we found a relationship between prolonged atrial conduc-
tion time and increased functional class, morbidity, and mortality 
in systolic HF patients. As a result, we believe that intra- and inter-
atrial conduction time can be used in the follow-up of patients with 
systolic HF and determination of the functional class and prognosis. 
However, our findings need to be supported by other studies includ-
ing a large number of patients and a long-term follow-up period.
Table 5. Correlation of PWD and intra- and inter-atrial dyssynchrony with other parameters
Variables Pwd  Intra-atrial dyssyncrony Inter-atrial dyssyncrony
  R P R P R P
HR 0.109 0.395 0.007 0.959 0.017  0.892
P max 0.917 0.001 0.571 0.001 0.604 0.001
P min 0.431 0.001 0.186 0.144 0.243 0.055
PR interval 0.050 0.699 –0.070 0.585 0.022 0.867
Pwd – – 0.606 0.001 0.631 0.001
LVEF –0.277 0.028 –0.284 0.024 –0.251 0.047
LAEF –0.100 0.435 0.032 0.806 –0.058 0.651
Intra-atrial dyssyncrony 0.606 0.001 – – 0.835 0.001
Inter-atrial dyssyncrony 0.631 0.001 0.835 0.001 – –
LA max 0.142 0.268 0.187 0.143 0.152 0.235
LA min –0.017 0.894 0.065 0.612 0.064 0.620
LA diastolic volume 0.313 0.013 0.484 0.001 0.544 0.001
LA systolic volume 0.332 0.008 0.440 0.001 0.547 0.001
QRS 0.079 0.536 0.161 0.208 0.098 0.445
QTc –0.002 0.985 0.124 0.335 0.192 0.133
E/E' septal annulus 0.066 0.609 0.056 0.665 0.046 0.723
Tricuspit PA 0.016 0.931 0.072 0.557 0.095 0.460
Septal PA 0.294 0.019 0.527 0.001 0.469 0.001
Lateral PA 0.330 0.008 0.480 0.001 0.583 0.001
PA time 0.454 0.001 0.589 0.001 0.462 0.001
LVDD 0.061 0.637 0.226 0.075 0.281 0.026
LVSD 0.041 0.747 0.254 0.045 0.253 0.045
RVS 0.059 0.647 0.012 0.924 0.004 0.976
RVE –0.064 0.617 –0.081 0.526 –0.136 0.288
RVA –0.036 0.778 0.032 0.805 –0.092 0.473
Septal S –0.060 0.639 0.105 0.414 0.023 0.856
Septal E –0.100 0.435 0.055 0.671 –0.148 0.249
Septal A –0.039 0.759 0.092 0.474 –0.039 0.761
Lateral S –0.043 0.734 -0.053 0.679 –0.045 0.727
Lateral E 0.080 0.531 0.270 0.033 0.199 0.118
Lateral A –0.011 0.932 –0.010 0.938 –0.074 0.563
E 0.057 0.655 0.089 0.487 –0.051 0.692
A 0.069 0.591 0.045 0.726 –0.046 0.720
Continuous data are expressed as mean±SD.
HR - heart rate; LAEF - left atrial ejection fraction; LVDD - left ventricular diastolic diameter; LVSD - left ventricular systolic diameter; LVEF - left ventricular ejection fraction; PA time-
onset of P-wave on surface ECG to the peak of trans mitral A-wave (PA- interatrial conduction time); Pmin - minimum P wave duration; Pmax - maximum wave duration; Pwd - P wave 
dispersion; QTc - corrected QT
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